Nexmedicare Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -46.14%
- Profit Growth 68.79%
- Ebitda 70.47%
- Net Worth -23.87%
- Total Assets 16.13%
About Nexmedicare Pharmaceutical
Nexmedicare Pharmaceutical Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2019 (Five years and 11 months 18 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Corporate was formerly known as Nexmedicare Biological And Pharmaceutical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Gupta and Nikhilesh Chaturvedi serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24304UP2019PTC113550
- Company No.
113550
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Nexmedicare Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Gupta  | Director | 12-Feb-2019 | Current |
| Nikhilesh Chaturvedi | Director | 12-Feb-2019 | Current |
Financial Performance of Nexmedicare Pharmaceutical.
Nexmedicare Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 46.14% decrease. The company also saw a substantial improvement in profitability, with a 68.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexmedicare Pharmaceutical?
Unlock access to Nexmedicare Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Newshyne Pharmaceuticals Private LimitedHimanshu Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nexmedicare Pharmaceutical?
Unlock and access historical data on people associated with Nexmedicare Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexmedicare Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexmedicare Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.